Position in PTGX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$141,702
+$19,333 QoQ
Shares Held
1,156
-0.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#268
of 341 holders
Holding Since
Jun 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Truvestments Capital LLC holds $2,122,733 across 78 Biotechnology names. PTGX ranks #3 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
7,833 | $426,193 | |
| 2 | CRVS |
Corvus Pharmaceuticals, Inc.
|
10,195 | $152,313 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
This page
|
1,156 | $141,702 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
3,788 | $134,057 | |
| 5 | CTMX |
CytomX Therapeutics, Inc.
|
27,988 | $104,955 | |
| 6 | TGTX |
Tg Therapeutics, Inc.
|
1,764 | $96,914 | |
| 7 | RIGL |
Rigel Pharmaceuticals Inc
|
2,387 | $93,379 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,229 | $91,535 |
All Filings in PTGX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $141,702 | 1,156 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $122,369 | 1,161 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $101,401 | 1,161 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $47,962 | 722 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $35,925 | 650 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $13,589 | 281 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $5,056 | 131 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $5,895 | 131 | Shares | Sole | 2024-11-13 | |
| 2024-03-31 | $3,789 | 131 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $3,003 | 131 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,185 | 131 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,618 | 131 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,013 | 131 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,763 | 345 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,908 | 345 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $2,728 | 345 | Shares | Sole | 2022-08-09 | |
| 2021-12-31 | $8,550 | 250 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $4,430 | 250 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $11,220 | 250 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $6,475 | 250 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $2,399 | 119 | Shares | Sole | 2021-02-17 | |
| 2020-06-30 | $2,101 | 119 | Shares | Sole | 2020-08-06 | |
| No filing history on record for this holder in this stock. | ||||||